OTC Markets OTCQB - Delayed Quote USD

Leef Brands Inc. (LEEED)

Compare
0.1560 +0.0004 (+0.26%)
At close: December 11 at 3:00:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
7/31/2021
Total Revenue
31,616.8830
30,520.7830
27,003.1570
33,457.0250
7,852.9396
Cost of Revenue
22,068.1920
20,591.4170
17,449.0720
25,042.7140
5,695.4904
Gross Profit
9,548.6920
9,929.3660
9,554.0850
8,414.3110
2,157.4492
Operating Expense
17,481.3790
16,543.2670
25,943.0150
11,168.0210
5,744.3339
Operating Income
-7,932.6870
-6,613.9010
-16,388.9300
-2,753.7100
-3,586.8847
Net Non Operating Interest Income Expense
-3,814.6440
-4,389.9180
-4,466.0570
-3,977.1870
-141.8223
Other Income Expense
--
-28,161.7910
-4,401.2970
681.5490
-3,034.9813
Pretax Income
-40,476.8010
-39,165.6100
-25,256.2830
-6,049.3480
-6,763.6883
Tax Provision
-5,072.4490
-4,959.1780
3,667.3180
1,680.7980
-424.8986
Net Income Common Stockholders
-35,404.3520
-34,206.4320
-28,923.6020
-7,730.1460
-6,338.7897
Diluted NI Available to Com Stockholders
-35,404.3520
-34,206.4320
-28,923.6020
-7,730.1460
-6,338.7897
Basic EPS
-0.31
-0.30
-0.40
-1.41
-0.24
Diluted EPS
-0.31
-0.30
-0.40
-1.41
-0.24
Basic Average Shares
127,208.9730
115,964.1960
73,179.1730
5,486.5710
22,830.7580
Diluted Average Shares
127,208.9730
115,964.1960
73,179.1730
5,486.5710
22,830.7580
Total Operating Income as Reported
-37,957.9990
-36,640.3590
-29,778.5790
2,753.7100
--
Rent Expense Supplemental
139.8460
136.1950
177.0550
155.6760
31.9600
Total Expenses
39,549.5710
37,134.6840
43,392.0870
36,210.7350
11,439.8243
Net Income from Continuing & Discontinued Operation
-35,404.3520
-34,206.4320
-28,923.6020
-7,730.1460
-6,338.7897
Normalized Income
-10,309.4067
-9,140.5394
-26,059.1111
-7,888.3849
-3,494.4676
Interest Income
--
--
--
--
0.2196
Interest Expense
3,814.6440
4,389.9180
4,466.0570
3,977.1870
142.0419
Net Interest Income
-3,814.6440
-4,389.9180
-4,466.0570
-3,977.1870
-141.8223
EBIT
-36,662.1570
-34,775.6920
-20,790.2260
-2,072.1610
-6,621.6464
EBITDA
-34,810.9490
-32,942.2870
-18,893.9120
-570.3340
-4,517.6978
Reconciled Cost of Revenue
22,128.6920
20,591.4170
17,449.0720
25,042.7140
5,695.4904
Reconciled Depreciation
1,790.7080
1,833.4050
1,896.3140
1,501.8270
2,103.9486
Net Income from Continuing Operation Net Minority Interest
-35,404.3520
-34,206.4320
-28,923.6020
-7,730.1460
-6,338.7897
Total Unusual Items Excluding Goodwill
-28,690.3460
-28,699.8940
-3,881.9500
215.2910
-3,034.9813
Total Unusual Items
-28,690.3460
-28,699.8940
-3,881.9500
215.2910
-3,034.9813
Normalized EBITDA
-6,120.6030
-4,242.3930
-15,011.9620
-785.6250
-1,482.7165
Tax Rate for Calcs
0.0001
0.0001
0.0003
0.0003
0.0001
Tax Effect of Unusual Items
-3,595.4007
-3,634.0014
-1,017.4591
57.0521
-190.6592
7/31/2021 - 1/8/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VIBEF Vibe Growth Corporation
0.0410
0.00%
 
NLBS NutraLife BioSciences, Inc.
0.0001
0.00%
 
PARNF Parnell Pharmaceuticals Holdings Ltd
0.0500
0.00%
 
HPST Hempstract, Inc.
0.0120
+41.18%
 
SBBCF Simply Better Brands Corp.
0.6479
-4.01%
 
CRYM Cryomass Technologies Inc.
0.0159
+1.92%
 
PAIOF Paion AG
0.0200
0.00%
 
WUHN Wuhan General Group (China), Inc.
0.0002
0.00%
 
AOLS Aeolus Pharmaceuticals, Inc.
0.0002
0.00%
 
CTTH CTT Pharmaceutical Holdings, Inc.
0.0490
0.00%